Tower Research Capital LLC (Trc) Hutchmed (China) LTD Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,261 shares of HCM stock, worth $17,401. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,261
Previous 3,495
63.92%
Holding current value
$17,401
Previous $68,000
73.53%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding HCM
# of Institutions
71Shares Held
6.99MCall Options Held
6.2KPut Options Held
1.1K-
Schroder Investment Management Group London, X02.77MShares$38.2 Million0.04% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1.12MShares$15.5 Million0.02% of portfolio
-
Ubs Group Ag378KShares$5.21 Million0.0% of portfolio
-
State Street Corp Boston, MA348KShares$4.8 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.35 Million0.12% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.39B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...